BC
UTHR icon

Burney Company’s United Therapeutics UTHR Stock Holding History

Burney Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.74M Sell
10,588
-69
-0.6% -$38.9K 0.15% 110
2026
Q1 		$6.32M Sell
10,657
-144
-1% -$71.7K 0.2% 97
2025
Q4 		$5.26M Sell
10,801
-440
-4% -$205K 0.16% 131
2025
Q3 		$4.71M Sell
11,241
-256
-2% -$86.1K 0.15% 143
2025
Q2 		$3.3M Sell
11,497
-420
-4% -$126K 0.11% 169
2025
Q1 		$3.67M Sell
11,917
-12,005
-50% -$4.11M 0.13% 151
2024
Q4 		$8.44M Buy
23,922
+12,705
+113% +$4.67M 0.3% 80
2024
Q3 		$4.02M Sell
11,217
-4,749
-30% -$1.6M 0.14% 156
2024
Q2 		$5.09M Sell
15,966
-6,483
-29% -$1.72M 0.19% 121
2024
Q1 		$5.16M Buy
22,449
+12,205
+119% +$2.75M 0.2% 125
2023
Q4 		$2.25M Buy
10,244
+280
+3% +$64.5K 0.09% 225
2023
Q3 		$2.25M Buy
9,964
+300
+3% +$69.1K 0.11% 211
2023
Q2 		$2.13M Sell
9,664
-172
-2% -$38.1K 0.1% 222
2023
Q1 		$2.2M Sell
9,836
-184
-2% -$45.4K 0.11% 209
2022
Q4 		$2.79M Sell
10,020
-43
-0.4% -$10.9K 0.14% 169
2022
Q3 		$2.11M Sell
10,063
-521
-5% -$116K 0.12% 195
2022
Q2 		$2.49M Sell
10,584
-20
-0.2% -$4.07K 0.13% 183
2022
Q1 		$1.9M Hold
10,604
– – 0.09% 241
2021
Q4 		$2.29M Sell
10,604
-309
-3% -$60.7K 0.1% 217
2021
Q3 		$2.01M Sell
10,913
-260
-2% -$51.2K 0.09% 221
2021
Q2 		$2M Sell
11,173
-49
-0.4% -$9.33K 0.09% 233
2021
Q1 		$1.88M Sell
11,222
-374
-3% -$62.4K 0.09% 233
2020
Q4 		$1.76M Sell
11,596
-487
-4% -$63.9K 0.1% 231
2020
Q3 		$1.22M Sell
12,083
-188
-2% -$20.6K 0.08% 254
2020
Q2 		$1.49M Sell
12,271
-464
-4% -$52.2K 0.1% 228
2020
Q1 		$1.21M Sell
12,735
-232
-2% -$22.1K 0.09% 215
2019
Q4 		$1.14M Sell
12,967
-515
-4% -$45.3K 0.06% 255
2019
Q3 		$1.07M Sell
13,482
-47,085
-78% -$3.79M 0.06% 249
2019
Q2 		$4.73M Sell
60,567
-6,913
-10% -$646K 0.29% 112
2019
Q1 		$7.92M Buy
67,480
+433
+0.6% +$50.5K 0.49% 57
2018
Q4 		$7.3M Sell
67,047
-5,882
-8% -$682K 0.51% 56
2018
Q3 		$9.33M Sell
72,929
-11,186
-13% -$1.38M 0.56% 47
2018
Q2 		$9.52M Sell
84,115
-27,318
-25% -$3M 0.56% 50
2018
Q1 		$12.5M Sell
111,433
-8,554
-7% -$1.09M 0.78% 34
2017
Q4 		$17.8M Buy
119,987
+3,499
+3% +$445K 1% 18
2017
Q3 		$13.8M Sell
116,488
-3,338
-3% -$426K 0.9% 25
2017
Q2 		$15.7M Buy
119,826
+237
+0.2% +$29.6K 1.03% 21
2017
Q1 		$16.2M Buy
119,589
+13,571
+13% +$2.06M 1.07% 23
2016
Q4 		$15.2M Buy
106,018
+6,032
+6% +$770K 1.03% 24
2016
Q3 		$11.9M Sell
99,986
-1,222
-1% -$147K 0.84% 34
2016
Q2 		$10.7M Sell
101,208
-1,775
-2% -$198K 0.77% 42
2016
Q1 		$11.5M Buy
102,983
+3,758
+4% +$476K 0.84% 31
2015
Q4 		$16M Sell
99,225
-382
-0.4% -$55.6K 1.18% 16
2015
Q3 		$13.1M Sell
99,607
-35,697
-26% -$5.73M 1.01% 25
2015
Q2 		$23.5M Sell
135,304
-7,469
-5% -$1.34M 1.6% 6
2015
Q1 		$24.6M Buy
142,773
+24,221
+20% +$3.69M 1.69% 4
2014
Q4 		$15.4M Sell
118,552
-1,695
-1% -$218K 1.22% 12
2014
Q3 		$15.5M Sell
120,247
-10,870
-8% -$1.12M 1.33% 10
2014
Q2 		$11.6M Buy
131,117
+8,734
+7% +$840K 1% 23
2014
Q1 		$11.5M Buy
122,383
+19,393
+19% +$1.98M 1.05% 23
2013
Q4 		$11.6M Buy
102,990
+42,030
+69% +$3.79M 1.13% 15
2013
Q3 		$4.81M Buy
60,960
+21,979
+56% +$1.61M 0.54% 63
2013
Q2 		$2.57M Buy
+38,981
New +$2.51M 0.32% 91

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Burney Company's UTHR Position: Q2 2026 in Review

Burney Company reduced its United Therapeutics (UTHR) stake by 0.65% in Q2 2026, selling an estimated $38.9K and leaving 10,588 shares worth $5.74M. The position accounts for 0.15% of the portfolio, ranked #110.

Burney Company first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.6M in Q1 2015. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Burney Company held 10,588 shares of United Therapeutics worth $5.74M as of Q2 2026.
  • Burney Company sold 69 United Therapeutics shares in Q2 2026, an estimated $38.9K.
  • United Therapeutics made up 0.15% of Burney Company's portfolio in Q2 2026, its #110 holding.
  • Burney Company first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • Burney Company's United Therapeutics position peaked at $24.6M in Q1 2015.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.